» Articles » PMID: 33224341

Construction of Relapse-related LncRNA-mediated CeRNA Networks in Hodgkin Lymphoma

Overview
Journal Arch Med Sci
Specialty General Medicine
Date 2020 Nov 23
PMID 33224341
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Hodgkin lymphoma (HL) is a type of lymphoma common throughout the western countries. However, the detailed mechanisms and special biomarkers of HL remain to be further investigated. Emerging studies have shown that long non-coding RNAs play a key role in human cancers.

Material And Methods: In the present work, we constructed relapse-related lncRNA-mediated ceRNA networks in HL. Additionally, we constructed co-expression networks for these relapse-related lncRNAs. We also constructed a relapse-related lncRNA-miRNA-mRNA network to study the potential mechanism of these lncRNAs. Furthermore, gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were performed to explore functions of DEGs in Hodgkin lymphoma.

Results: A total of 18 lncRNAs were found to be dysregulated between early relapse and late relapse HL. Six lncRNAs (PCBP1-AS1, HCG18, GAS5, PSMD6-AS2, PRKCQ-AS1, SNHG6), 116 mRNAs and 121 miRNAs were included in the ceRNA network. Bioinformatics analyses revealed that these lncRNAs were significantly involved in regulating immune system processes, responses to chemical stimuli and responses to stress. Among them, HCG18 and PCBP1-AS1 were identified as key lncRNAs in HL relapse.

Conclusions: Our results for the first time constructed the key relapse-related lncRNA-mediated ceRNA networks in Hodgkin lymphoma progression. We trust that this work will provide a new therapeutic and prognostic target for HL.

Citing Articles

PGM5-AS1 Promotes Progression of Diffuse Large B-Cell Lymphoma and Immune Escape by Regulating miR-503-5p.

Qin X, Li H, Wu J, Tang W, Li W, Li K J Inflamm Res. 2024; 17:4187-4197.

PMID: 38973995 PMC: 11225957. DOI: 10.2147/JIR.S453245.


Expression of lncRNAs in children with pancreaticobiliary maljunction: functional analysis and potential biomarkers.

Zhao L, Shi S, Guo W Arch Med Sci. 2024; 20(2):528-538.

PMID: 38757013 PMC: 11094826. DOI: 10.5114/aoms/145482.


Identification and Validation of Ferroptosis-Related LncRNAs Signature as a Novel Prognostic Model for Chronic Lymphocytic Leukemia.

Xu Z, Pan B, Li Y, Xia Y, Liang J, Kong Y Int J Gen Med. 2023; 16:1541-1553.

PMID: 37131869 PMC: 10149066. DOI: 10.2147/IJGM.S399629.


The role of long non-coding RNA HCG18 in cancer.

Wang Z, Ran R, Zhang S, Zhou W, Lv J, Ma C Clin Transl Oncol. 2022; 25(3):611-619.

PMID: 36346572 DOI: 10.1007/s12094-022-02992-8.


Role of Bioinformatics Analysis in Early Differential Diagnosis of Ovarian Cancer.

Zhang L, Zhao Y, Li L, Xin H Contrast Media Mol Imaging. 2022; 2022:6129817.

PMID: 36185577 PMC: 9507672. DOI: 10.1155/2022/6129817.


References
1.
Kornienko A, Guenzl P, Barlow D, Pauler F . Gene regulation by the act of long non-coding RNA transcription. BMC Biol. 2013; 11:59. PMC: 3668284. DOI: 10.1186/1741-7007-11-59. View

2.
Xi Y, Jiang T, Wang W, Yu J, Wang Y, Wu X . Long non-coding HCG18 promotes intervertebral disc degeneration by sponging miR-146a-5p and regulating TRAF6 expression. Sci Rep. 2017; 7(1):13234. PMC: 5643303. DOI: 10.1038/s41598-017-13364-6. View

3.
Ruan J, Zheng L, Hu N, Guan G, Chen J, Zhou X . Long noncoding RNA SNHG6 promotes osteosarcoma cell proliferation through regulating p21 and KLF2. Arch Biochem Biophys. 2018; 646:128-136. DOI: 10.1016/j.abb.2018.03.036. View

4.
Wang Z, Yang B, Zhang M, Guo W, Wu Z, Wang Y . lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer. Cancer Cell. 2018; 33(4):706-720.e9. PMC: 6143179. DOI: 10.1016/j.ccell.2018.03.006. View

5.
Wu Y, Lyu H, Liu H, Shi X, Song Y, Liu B . Downregulation of the long noncoding RNA GAS5-AS1 contributes to tumor metastasis in non-small cell lung cancer. Sci Rep. 2016; 6:31093. PMC: 4973264. DOI: 10.1038/srep31093. View